Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2023 · 10-Q
Revenue$58.75M$58.75M+63.9% vs Q2 2022 Net Income$1.31M$1.31M−64.9% vs Q2 2022 EPS Diluted$0.24$0.24−65.7% vs Q2 2022 Gross Profit$36,386,000+57.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$10,557,000+138.1% Free Cash Flowderived$8,918,000+155.1% Margins · derivedGross margin61.9%−2.6 pt vs Q2 2022
Operating margin6.8%−4.9 pt vs Q2 2022
Net margin2.2%−8.2 pt vs Q2 2022
ended Sep 30, 2022 · filed Nov 3, 2022 · 34 d after period end